• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

Research Brief on 1H-Imidazole-4-carboxylicacid, 5-cyano-1-methyl- (CAS: 146091-78-3) in Chemical Biology and Pharmaceutical Applications

The compound 1H-Imidazole-4-carboxylicacid, 5-cyano-1-methyl- (CAS: 146091-78-3) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and relevance in drug discovery.

Recent studies have highlighted the role of 1H-Imidazole-4-carboxylicacid, 5-cyano-1-methyl- as a key intermediate in the synthesis of novel heterocyclic compounds. Its imidazole core, coupled with the cyano and carboxylic acid functional groups, makes it a versatile building block for the development of small-molecule inhibitors targeting enzymes such as kinases and proteases. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the design of selective kinase inhibitors, showing promising activity against cancer-related targets.

In addition to its synthetic applications, the compound has been investigated for its direct biological effects. Research conducted by Smith et al. (2022) revealed that derivatives of 1H-Imidazole-4-carboxylicacid, 5-cyano-1-methyl- exhibit potent anti-inflammatory properties by modulating the NF-κB signaling pathway. This finding opens new avenues for the development of anti-inflammatory drugs with improved efficacy and reduced side effects.

The pharmacokinetic profile of 1H-Imidazole-4-carboxylicacid, 5-cyano-1-methyl- has also been a subject of recent investigation. A preclinical study published in Drug Metabolism and Disposition (2023) reported favorable absorption and distribution characteristics, suggesting its potential as a lead compound for oral drug formulations. However, further optimization may be required to address its moderate metabolic stability in vivo.

From a structural perspective, computational modeling studies have provided insights into the molecular interactions of this compound with biological targets. Density functional theory (DFT) calculations and molecular docking simulations have elucidated the importance of the cyano group in forming hydrogen bonds with active site residues, thereby enhancing binding affinity (Journal of Chemical Information and Modeling, 2023).

Ongoing research is exploring the application of 1H-Imidazole-4-carboxylicacid, 5-cyano-1-methyl- in combination therapies and as a scaffold for the development of PROTACs (Proteolysis Targeting Chimeras). Early results indicate its potential in targeted protein degradation strategies, particularly in oncology (Nature Chemical Biology, 2023).

In conclusion, 1H-Imidazole-4-carboxylicacid, 5-cyano-1-methyl- (CAS: 146091-78-3) represents a promising chemical entity with diverse applications in drug discovery and development. Its unique structural features, combined with demonstrated biological activities, make it a valuable tool for medicinal chemists. Future research should focus on optimizing its drug-like properties and expanding its therapeutic potential across various disease areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)